Better pharmaceuticals for children : assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session on examining the impact of the pediatric exclusivity provision of the better pharmaceuticals for children act, which grants a pharmaceutical company an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the Food and Drug Administration, May 8, 2001.
Saved in:
Corporate Author: | United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author) |
---|---|
Format: | Online |
Language: | English |
Published: |
Washington :
U.S. Government Printing Office,
2001.
|
Series: | U.S. Congressional documents. Congressional hearings.
|
Subjects: | |
Online Access: | HeinOnline U.S. Congressional Documents Collection |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Legislative history Best Pharmaceuticals for Children Act : (P.L. 107-109, 115 Stat. 1408) /
Published: (2002) -
International pharmaceutical law and practice.
Published: (2012) -
Johnson & Johnson's recall of Children's Tylenol and other children's medicines. hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session.
Published: (2011) -
Johnson & Johnson's recall of Children's Tylenol and other children's medicines : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session
Published: (2011) -
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
Published: (2001)